Survival and toxicity in patients with human papilloma virus‐associated oropharyngeal squamous cell cancer receiving trimodality therapy including transoral robotic surgery
Volume: 43, Issue: 10, Pages: 3053 - 3061
Published: Jun 25, 2021
Abstract
Background Patients with oropharyngeal cancer who undergo transoral robotic surgery (TORS) and have high‐risk features generally receive adjuvant chemoradiotherapy or trimodality therapy (TMT). The notion that TMT leads to high toxicity is largely based on studies that included human papilloma virus (HPV)‐negative cancers and/or nonrobotic surgery; we sought to describe outcomes in HPV‐associated oropharyngeal squamous cell cancer (HPV + OPSCC)...
Paper Details
Title
Survival and toxicity in patients with human papilloma virus‐associated oropharyngeal squamous cell cancer receiving trimodality therapy including transoral robotic surgery
Published Date
Jun 25, 2021
Volume
43
Issue
10
Pages
3053 - 3061
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History